172 related articles for article (PubMed ID: 28281027)
1. Proteasome inhibitors against amelanotic melanoma.
Sidor-Kaczmarek J; Cichorek M; Spodnik JH; Wójcik S; Moryś J
Cell Biol Toxicol; 2017 Dec; 33(6):557-573. PubMed ID: 28281027
[TBL] [Abstract][Full Text] [Related]
2. The activity of caspases in spontaneous and camptothecin-induced death of melanotic and amelanotic melanoma cell.
Cichorek M; Kozłowska K; Bryl E
Cancer Biol Ther; 2007 Mar; 6(3):346-53. PubMed ID: 17312383
[TBL] [Abstract][Full Text] [Related]
3. Camptothecin-induced death of amelanotic and melanotic melanoma cells in different phases of cell cycle.
Cichorek M
Neoplasma; 2011; 58(3):227-34. PubMed ID: 21391739
[TBL] [Abstract][Full Text] [Related]
4. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A
Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365
[TBL] [Abstract][Full Text] [Related]
5. The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma.
Suarez-Kelly LP; Kemper GM; Duggan MC; Stiff A; Noel TC; Markowitz J; Luedke EA; Yildiz VO; Yu L; Jaime-Ramirez AC; Karpa V; Zhang X; Carson WE
Oncotarget; 2016 Dec; 7(49):81172-81186. PubMed ID: 27783987
[TBL] [Abstract][Full Text] [Related]
6. Increased level of p27 subunit of proteasomes and its co-localization with tyrosinase in amelanotic melanoma cells indicate its direct role in the regulation of melanin biosynthesis.
Godbole D; Mojamdar M; Pal JK
Cell Biol Int; 2006 Nov; 30(11):895-902. PubMed ID: 16879986
[TBL] [Abstract][Full Text] [Related]
7. Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines.
Sorolla A; Yeramian A; Dolcet X; Pérez de Santos AM; Llobet D; Schoenenberger JA; Casanova JM; Soria X; Egido R; Llombart A; Vilella R; Matias-Guiu X; Marti RM
Br J Dermatol; 2008 Mar; 158(3):496-504. PubMed ID: 18205878
[TBL] [Abstract][Full Text] [Related]
8. Mcl-1 Inhibitor Induces Cells Death in BRAF-Mutant Amelanotic Melanoma Trough GSH Depletion, DNA Damage and Cell Cycle Changes.
Respondek M; Beberok A; Rzepka Z; Rok J; Wrześniok D
Pathol Oncol Res; 2020 Jul; 26(3):1465-1474. PubMed ID: 31432325
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells.
Iskandarani A; Bhat AA; Siveen KS; Prabhu KS; Kuttikrishnan S; Khan MA; Krishnankutty R; Kulinski M; Nasr RR; Mohammad RM; Uddin S
J Transl Med; 2016 Mar; 14():69. PubMed ID: 26956626
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of proteasome function induced apoptosis in gastric cancer.
Fan XM; Wong BC; Wang WP; Zhou XM; Cho CH; Yuen ST; Leung SY; Lin MC; Kung HF; Lam SK
Int J Cancer; 2001 Aug; 93(4):481-8. PubMed ID: 11477551
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells.
Qin JZ; Ziffra J; Stennett L; Bodner B; Bonish BK; Chaturvedi V; Bennett F; Pollock PM; Trent JM; Hendrix MJ; Rizzo P; Miele L; Nickoloff BJ
Cancer Res; 2005 Jul; 65(14):6282-93. PubMed ID: 16024630
[TBL] [Abstract][Full Text] [Related]
12. The role of MITF and Mcl-1 proteins in the antiproliferative and proapoptotic effect of ciprofloxacin in amelanotic melanoma cells: In silico and in vitro study.
Beberok A; Rok J; Rzepka Z; Marciniec K; Boryczka S; Wrześniok D
Toxicol In Vitro; 2020 Aug; 66():104884. PubMed ID: 32437906
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications.
Fernández Y; Verhaegen M; Miller TP; Rush JL; Steiner P; Opipari AW; Lowe SW; Soengas MS
Cancer Res; 2005 Jul; 65(14):6294-304. PubMed ID: 16024631
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic window for melanoma treatment provided by selective effects of the proteasome on Bcl-2 proteins.
Wolter KG; Verhaegen M; Fernández Y; Nikolovska-Coleska Z; Riblett M; de la Vega CM; Wang S; Soengas MS
Cell Death Differ; 2007 Sep; 14(9):1605-16. PubMed ID: 17541428
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibition as a novel mechanism of the proapoptotic activity of γ-secretase inhibitor I in cutaneous T-cell lymphoma.
Biskup E; Kamstrup MR; Manfé V; Gniadecki R
Br J Dermatol; 2013 Mar; 168(3):504-12. PubMed ID: 23445313
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells.
Selimovic D; Porzig BB; El-Khattouti A; Badura HE; Ahmad M; Ghanjati F; Santourlidis S; Haikel Y; Hassan M
Cell Signal; 2013 Jan; 25(1):308-18. PubMed ID: 23079083
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
Altmann A; Markert A; Askoxylakis V; Schöning T; Jesenofsky R; Eisenhut M; Haberkorn U
J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibitors and Smac mimetics cooperate to induce cell death in diffuse large B-cell lymphoma by stabilizing NOXA and triggering mitochondrial apoptosis.
Dietz A; Dalda N; Zielke S; Dittmann J; van Wijk SJL; Vogler M; Fulda S
Int J Cancer; 2020 Sep; 147(5):1485-1498. PubMed ID: 32170726
[TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process.
Dai Y; Rahmani M; Grant S
Oncogene; 2003 Oct; 22(46):7108-22. PubMed ID: 14562039
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I mediates neuroprotection in proteasome inhibition-induced cytotoxicity in SH-SY5Y cells.
Cheng B; Maffi SK; Martinez AA; Acosta YP; Morales LD; Roberts JL
Mol Cell Neurosci; 2011 Jul; 47(3):181-90. PubMed ID: 21545837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
